arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

INVO Fertility, Inc.

IVF
$2.03 ▼ -0.02 (-0.98%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
57 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

INVO Fertility, Inc. faces fundamental challenges with weakness in Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $4.3M
Dividend Yield —
Revenue Growth 16.7% ↘
Op. Margin -59.3% ↗
ROIC -7.1% ↗
FCF / Share $-0.52 ↗
Trailing P/E 4.8x
Price / Book 0.3x
FCF Yield —
Debt / Equity 0.03
info Valuation on last close. End-of-day price, Nov 5, 2026.

57-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.18M
↑ +16.7% —
Net Income Profit after all expenses
$-5.54M
↑ +68.2% —
Operating Margin Operating profit as % of sales
-59.3%
↑ +24.9% 2th
FCF / Share Free cash flow per share
$-0.52
↑ +55.3% —
Long-Term Debt Long-term obligations
$513.39K
↓ -22.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
2
Financial Health ↓
53
Cash Quality ↓
33

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 57 quarters